
Venture capital · Early stage · Est. 2009
Mission BioCapital
Mission BioCapital is a life science venture firm with offices in San Francisco and Cambridge. It backs early-stage therapeutics companies, and also medtech and diagnostics, and runs shared lab spaces and a Platinum Program for startups.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Mission BioCapital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Mission BioCapital joined, from press and the firm’s own posts.
3 rounds in the last 12 months
Round sizes, Mission BioCapital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Mission BioCapital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Mission BioCapital
Events where Mission BioCapital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Mission BioCapital is based in Cambridge, United States. It also has offices in San Francisco and Copenhagen.
In 2009.
4 fund vehicles are on public registers (SEC adviser filings), including MISSION BIOCAPITAL V LP, BIOINNOVATION CAPITAL I LP and MISSION BIOCAPITAL VI LP.
Stages: Early stage. Sectors: Biotech, Life sciences, Medtech. From the firm’s own website.
The firm provides early capital and a collaborative platform, including shared labs, to life science entrepreneurs, supporting them from the first experiment toward the clinic. It prefers novel therapeutics, is disease- and modality-agnostic, and adds mentorship, operating help and company-building support. From the firm’s own website.
Up to $500K per investment, according to the firm’s own website.
Mission BioCapital lists 96 portfolio companies on its website, including March Biosciences, Asherbio, Applaud Medical, Cavalry Biosciences and Sensorium Therapeutics.
Firms whose websites list some of the same companies include AWESOME ENABLERS, L.L.C., Inkef and RA Capital.
Know before Mission BioCapital’s next round is announced.
PRO tracks Mission BioCapital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.